• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.

作者信息

Dempster D W

出版信息

J Bone Miner Res. 1997 Aug;12(8):1152-4. doi: 10.1359/jbmr.1997.12.8.1152.

DOI:10.1359/jbmr.1997.12.8.1152
PMID:9258744
Abstract
摘要

相似文献

1
Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.利用并绕过骨重塑周期以优化骨质疏松症的治疗。
J Bone Miner Res. 1997 Aug;12(8):1152-4. doi: 10.1359/jbmr.1997.12.8.1152.
2
Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.甲状旁腺激素和阿仑膦酸钠单独或联合使用对骨质疏松症的影响。
N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.
3
Combination and sequential therapy for osteoporosis.骨质疏松症的联合及序贯治疗
N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.
4
[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].[甲状旁腺与骨骼。骨质疏松症患者甲状旁腺治疗的证据与前景]
Clin Calcium. 2007 Dec;17(12):1888-94.
5
Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.甲状旁腺激素与阿仑膦酸钠单独或联合应用对骨质疏松症的影响。
N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.
6
Decimal point--osteoporosis therapy at the 10-year mark.小数点——骨质疏松症治疗十年之际。
N Engl J Med. 2004 Mar 18;350(12):1172-4. doi: 10.1056/NEJMp048017.
7
Mechanisms of bone loss and gain in untreated and treated osteoporosis.未经治疗和已治疗的骨质疏松症中骨质流失和增加的机制。
Endocrine. 2002 Feb;17(1):21-7. doi: 10.1385/ENDO:17:1:21.
8
Alendronate: a bisphosphonate for treatment of osteoporosis.阿仑膦酸盐：一种用于治疗骨质疏松症的双膦酸盐类药物。
Am Fam Physician. 1996 Nov 1;54(6):2053-60.
9
Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.绝经后骨质疏松症抗吸收治疗的作用机制
Endocr Regul. 2003 Dec;37(4):225-38.
10
Ten years of alendronate treatment for osteoporosis in postmenopausal women.十年阿仑膦酸钠治疗绝经后妇女骨质疏松症
N Engl J Med. 2004 Jul 8;351(2):190-2; author reply 190-2. doi: 10.1056/NEJM200407083510218.

引用本文的文献

1
Current Concepts and Methods in Tissue Interface Scaffold Fabrication.组织界面支架制造的当前概念与方法
Biomimetics (Basel). 2022 Oct 4;7(4):151. doi: 10.3390/biomimetics7040151.
2
Advances and Unmet Needs in the Therapeutics of Bone Fragility.骨脆性治疗的进展与未满足需求
Front Endocrinol (Lausanne). 2018 Sep 6;9:505. doi: 10.3389/fendo.2018.00505. eCollection 2018.
3
Bone histomorphometry in the evaluation of osteomalacia.骨组织形态计量学在骨软化症评估中的应用
Bone Rep. 2018 Mar 17;8:125-134. doi: 10.1016/j.bonr.2018.03.005. eCollection 2018 Jun.
4
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis.骨建模与重塑：作为骨质疏松症治疗靶点的潜力。
Ther Adv Musculoskelet Dis. 2016 Dec;8(6):225-235. doi: 10.1177/1759720X16670154. Epub 2016 Oct 5.
5
Pycnogenol(®) treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats.碧萝芷（®）治疗可抑制去卵巢大鼠的骨密度丢失和小梁退变。
Int J Clin Exp Med. 2015 Jul 15;8(7):10893-901. eCollection 2015.
6
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.双膦酸盐和降钙素对骨细胞和成骨细胞凋亡的预防作用。
J Clin Invest. 1999 Nov;104(10):1363-74. doi: 10.1172/JCI6800.
7
The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.甲状旁腺激素的骨生成作用：对骨质疏松症治疗的启示。
Drugs Aging. 1999 Aug;15(2):117-29. doi: 10.2165/00002512-199915020-00005.
8
Fast and slow bone losers. Relevance to the management of osteoporosis.快速和缓慢骨质流失者。与骨质疏松症管理的相关性。
Drugs Aging. 1998;12 Suppl 1:1-7. doi: 10.2165/00002512-199812001-00001.